Fate Therapeutics Inc
Ticker: FATE
| Insider | Title |
|---|---|
| Bahram Valamehr | Chief RD Officer |
| Brian T. Powl | Chief Commercial Officer |
| Cindy Tahl | General Counsel and Secretary |
| Edward J Iii Dulac | Chief Financial Officer |
| Group, Llc Redmile | Director, 10% or greater ownership |
| J Scott Wolchko | President and CEO, Director |
| Jeremy Green | Director, 10% or greater ownership |
| Jerome Charles Bressi | See Remarks |
| John Mendlein | Director |
| Karin Jooss | Director |
| Mark Plavsic | Chief Technical Officer |
| Michael Stewart Lee | Director |
| Neelufar Mozaffarian | Director |
| Robert Hershberg | Director |
| Robert S Epstein | Director |
| Shefali Agarwal | Director |
| Timothy Coughlin | Director |
| William H Rastetter | Director |
| Yu-waye Chu | Chief Medical Officer |
| Yuan Xu | Director |